ERBB2 and metastatic malignant neoplasm in the lymph nodes: Compared with low/intermediate histologic grade ER+HER2− patients, grade III cases tended to have earlier age at diagnosis, larger tumors, greater risk of lymph node metastasis, and a higher chance of receiving chemotherapy.